Maria Evangelia Adami, Antigone Kotsaki, Nikolaos Antonakos, Efthymia Giannitsioti, Stamatios Chalvatzis, Maria Saridaki, Christina Avgoustou, Karolina Akinosoglou, Konstantina Dakou, Georgia Damoraki, Konstantina Katrini, Panagiotis Koufargyris, Vasileios Lekakis, Antonia Panagaki, Asimina Safarika, Jesper Eugen‐Olsen and Evangelos J. Giamarellos-Bourboulis

Critical Care volume 28, Article number: 42 (2024)
DOI: 10.1186/s13054-024-04825-2Download pdf 🡇

Funding

The work was sponsored by the Hellenic Institute for the Study of Sepsis (HISS) and funded by HISS and ViroGates A/S. ViroGates A/S did not have any role in study design, analysis and interpretation of the data, and decision to publish. HISS designed the study, analyzed the data and decided to publish.

Keywords: Meropenem; sepsis; risk; suPAR

Related Study: SUPERIOR